[Hydrocortisone-17-butyrate (0.1 percent) versus hydrocortisone acetate (1 percent) in atopic dermatitis. Controlled double-blind study of 20 children].
D000287:Administration, Topical; D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D007223:Infant; D008297:Male
D000893:Anti-Inflammatory Agents; D003879:Dermatologic Agents; C007975:hydrocortisone-17-butyrate; C021650:hydrocortisone acetate; D006854:Hydrocortisone
L'idrocortisone 17-butirrato (0,1 percento) verso l'idrocortisone acetato (1 percento) nella dermatite atopica. Studio controllato a doppio cieco in 20 bambini.